You are here
Shal Technologies, Inc.
Company Information
Information
UEI: NMX2K239PXD8
# of Employees: 3
Ownership Information
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
A new small molecule targeting agent and therapeutic for non-Hodgkin's lymphoma
Amount: $1,583,930.00DESCRIPTION provided by applicant The goal of this SBIR proposal is to complete the majority of the pre clinical studies and testing needed to submit an IND application and advance a promising new ...
SBIRPhase II2014Department of Health and Human Services National Institutes of Health -
A new small molecule targeting agent and therapeutic for non-Hodgkin's lymphoma
Amount: $149,959.00DESCRIPTION (provided by applicant): The goal of this SBIR project is to complete the preclinical studies required to submit an IND application for a promising new therapeutic (SH7139) for non-Hodgkin ...
SBIRPhase I2011Department of Health and Human Services National Institutes of Health